Image-based drug screening combined with molecular profiling identifies signatures and drivers of therapy resistance in pediatric AML.
Cell reports. Medicine
View this publicationClinic for Pediatric Immunology and Rheumatology
Venusberg-Campus 1, 53127 Bonn
The research of Kaan Boztug focuses on uncovering the genetic and molecular foundations of rare immune system disorders. His work has led to the discovery of more than 20 previously unknown inborn errors of immunity. These findings have been pivotal in elucidating the roles of specific genes and proteins in immune system dysfunction, with a focus on immunodeficiencies characterised by susceptibility to infections, as well as immune dysregulation that influence autoimmunity and autoinflammation.
